| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |